Lordick F, Thuss-Patience P, Bitzer M, Maurus D, et al. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer. J Cancer Res Clin Oncol 2023;149:5937-5950.
PMID: 36607429